Skip to Content

WPI 1118 (Mirtazapine 30 mg)

Pill imprint WPI 1118 has been identified as Mirtazapine 30 mg.

Mirtazapine is used in the treatment of major depressive disorder; insomnia; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 30 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mirtazapine 30 mg WPI 1118
WPI 1118
30 mg
13.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Tetracyclic antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Watson Pharmaceuticals
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
ferric oxide yellow
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
58016-0986 Southwood Pharmaceuticals Inc (repackager)
16590-0154 Stat RX USA LLC (repackager)
18837-0094 Innoviant Pharmacy Inc (repackager)
68258-7005 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.